Aspirin anhydride (ASAN) has been found to be a frequent contaminant of commercial acetylsalicylic acid (ASA) preparations. ASAN is a highly immunogenic substance susceptible to form protein conjugates in vitro, to induce the formation of anti-aspiryl antibodies and of contact hypersensitivity to ASAN in guinea pigs and rabbits. Commercial ASA samples varied greatly in their capacity to induce hypersensitivity to ASAN under standardized conditions in guinea pigs. As demonstrated with various types of aspiryl-protein conjugates, antibodies induced by ASAN and detected by passive cutaneous anaphylaxis are mostly of aspiryl specificity. Antibodies of similar specificity have been detected in patients ingesting aspirin. A few patients presenting a reliable history of generalized urticaria and acute angioneurotic edema after ingestion of aspirin showed skin hypersensitivity to aspirylpolylysine. The possible significance of contamination of acetylsalicylic acid preparations by aspirin anhydride in the development of untoward reactions to aspirin is discussed.

This content is only available via PDF.
© 1971 S. Karger AG, Basel
1971
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.